Efficacy and Safety of Weekly Liquid Alendronate Sodium Trihydrate in Korean Postmenopausal Women with Osteoporosis: A 12-Month, Multi-Center, Randomized Trial

被引：0
|
作者：
Rhee, Y. [1 ]
Ahn, S. [2 ]
Hong, N. [1 ]
Seo, D. [2 ]
Hong, S. [2 ]
机构：
[1] Yonsei Univ, Endocrine Res Inst, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Inha Univ, Inha Univ Hosp, Sch Med, Incheon, South Korea
来源：
JOURNAL OF THE ENDOCRINE SOCIETY | 2024年 / 8卷
关键词：
D O I：
10.1210/jendso/bvae163.414
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6986
引用
收藏
页码：A221 / A221
页数：1
相关论文
共 50 条
  • [21] Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Chapurlat, Roland
    DaSilva, Carolyn
    Scott, Boyd B.
    De Tilleghem, Celine Le Bailly
    Leung, Albert T.
    Gurner, Deborah
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4727 - 4735
  • [22] Efficacy and safety of Changfu peritoneal dialysis solution:a multi-center prospective randomized controlled trial
    ZHOU Jian-hui
    NI Zhao-hui
    MEI Chang-lin
    YU Xue-qing
    LIU Fu-you
    MIAO Li-ning
    LIU Zhi-hong
    YUAN Wei-jie
    ZHANG Ai-ping
    LIN Hong-li
    CHEN Meng-hua
    CHEN Jiang-hua
    ZHANG Jin-yuan
    HE Ya-ni
    CHEN Jian
    ZHAO Jiu-yang
    DING Xiao-qiang
    LI Ying
    LI Rong-shan
    XIE Ru-juan
    LIU Wen-hu
    XING Chang-ying
    WANG Rong
    DENG Yue-yi
    CAO Xue-ying
    CAI Guang-yan
    MOU Shan
    MAO Zhi-guo
    YANG Xiao
    LIU Hong
    SUN Jing
    YU Yu-sheng
    LIU Jun
    SHI Shu-mei
    LI Long-kai
    TIAN Na
    ZHANG Xiao-hui
    ZHOU Wei
    YANG Jie
    ZHANG Yong
    SUN Jing-di
    JI Jun
    ZHANG Tao
    YAN Yan
    LIU Xiao-gang
    WANG Gang
    ZHANG Li
    ZHANG Hong
    LUO Jian-hua
    CHEN Xiang-mei
    中华医学杂志（英文版）, 2013, 126 (22) : 4204 - 4209
  • [23] Efficacy and safety of Changfu peritoneal dialysis solution: a multi-center prospective randomized controlled trial
    Zhou Jian-hui
    Ni Zhao-hui
    Mei Chang-lin
    Yu Xue-qing
    Liu Fu-you
    Miao Li-ning
    Liu Zhi-hong
    Yuan Wei-jie
    Zhang Ai-ping
    Lin Hong-li
    Chen Meng-hua
    Chen Jiang-hua
    Zhang Jin-yuan
    He Ya-ni
    Chen Jian
    Zhao Jiu-yang
    Ding Xiao-qiang
    Li Ying
    Li Rong-shan
    Xie Ru-juan
    Liu Wen-hu
    Xing Chang-ying
    Wang Rong
    Deng Yue-yi
    Cao Xue-ying
    Cai Guang-yan
    Mou Shan
    Mao Zhi-guo
    Yang Xiao
    Liu Hong
    Sun Jing
    Yu Yu-sheng
    Liu Jun
    Shi Shu-mei
    Li Long-kai
    Tian Na
    Zhang Xiao-hui
    Zhou Wei
    Yang Jie
    Zhang Yong
    Sun Jing-di
    Ji Jun
    Zhang Tao
    Yan Yan
    Liu Xiao-gang
    Wang Gang
    Zhang Li
    Zhang Hong
    Luo Jian-hua
    Chen Xiang-mei
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4204 - 4209
  • [24] Prunes preserve hip bone mineral density in a 12-month randomized controlled trial in postmenopausal women: the Prune Study
    De Souza, Mary Jane
    Strock, Nicole C. A.
    Williams, Nancy, I
    Lee, Hang
    Koltun, Kristen J.
    Rogers, Connie
    Ferruzzi, Mario G.
    Nakatsu, Cindy H.
    Weaver, Connie
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2022, 116 (04): : 897 - 910
  • [25] Growth hormone reduces inflammation in postmenopausal women with abdominal obesity:: A 12-month, randomized, placebo-controlled trial
    Franco, Celina
    Andersson, Bjorn
    Lonn, Lars
    Bengtsson, Bengt-Ake
    Svensson, Johan
    Johannsson, Gudmundur
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07): : 2644 - 2647
  • [26] Multi-center trial evaluating the 6 and 12 mo efficacy and safety of the Perigee System with IntePro
    Moore, R.
    Beyer, R.
    Jacoby, K.
    Freedman, S.
    McCammon, K.
    Gambla, M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S86 - S87
  • [27] Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
    Baek, Ki-Hyun
    Chung, Yoon-Sok
    Koh, Jung-Min
    Kim, In Joo
    Kim, Kyoung Min
    Min, Yong-Ki
    Park, Ki Deok
    Dinavahi, Rajani
    Maddox, Judy
    Yang, Wenjing
    Kim, Sooa
    Lee, Sang Jin
    Cho, Hyungjin
    Lim, Sung-Kil
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 60 - 69
  • [28] Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study
    Kobayakawa, Tomonori
    Miyazaki, Akiko
    Takahashi, Jun
    Nakamura, Yukio
    BONE, 2022, 162
  • [29] Efficacy and Safety of Weekly Alendronate Plus Vitamin D3 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial (vol 55, pg 715, 2014)
    Kim, Kwang Joon
    Min, Yong-Ki
    Koh, Jung-Min
    Chung, Yoon-Sok
    Kim, Kyoung Min
    Byun, Dong-Won
    Kim, In Joo
    Kim, Mikyung
    Kim, Sung-Soo
    Min, Kyung Wan
    Han, Ki Ok
    Park, Hyoung Moo
    Shin, Chan Soo
    Choi, Sung Hee
    Park, Jong Suk
    Chung, Dong Jin
    Mok, Ji Oh
    Baek, Hong Sun
    Moon, Seong-Hwan
    Kim, Yong Soo
    Lim, Sung-Kil
    YONSEI MEDICAL JOURNAL, 2014, 55 (04) : 1163 - 1163
  • [30] ARZOXIFENE VERSUS RALOXIFENE: 12-MONTH EFFECTS ON BONE MINERAL DENSITY, BONE TURNOVER MARKERS, AND SAFETY PARAMETERS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Zanchetta, J.
    Palacios, S.
    Cox, D.
    Stock, J.
    Dowsett, S.
    Kendler, D.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 14 - 15
12345